For Nurses and healthcare providers

Slides:



Advertisements
Similar presentations
Drug Information for Consumers and Healthcare Professionals Food and Drug Law Institute Annual Meeting Alan Goldhammer, PhD Associate VP Regulatory Affairs.
Advertisements

Member refers to plan member, an individual eligible for prescription drug benefits under a plan. ©2010 Caremark. All rights reserved. This presentation.
Management of Drug Formulary Dimitry Gotlinsky Western University Managed Care Clerkship ProPharma Pharmaceutical Consultants, Inc. 06/16/06.
Creating, Selecting and Positioning of Fair Balance in HCP drug advertising Dannie Newman PAAB Reviewer
FDA Pharmacogenetic Labels A Clinical Perspective David A Flockhart MD, PhD Indiana University School of Medicine Clinical Pharmacology Subcommittee of.
HeSCA 2002, Winnipeg Handheld Computers in Medicine Christopher A. Sarley Lehigh Valley Hospital Allentown, Pa.
All material proprietary and confidential. Presented by Teladoc, Inc. Teladoc Physician Training Module 8 | 2012.
January 16, 2010 Monica Robinson Green, PharmD, BCPS.
Corporate Communications 2012 Primary Care Specialty Survey November 2012.
MSU HealthTeam Michigan State University WHAT’S NEW IN 9.2.
Pharmacology Application in Athletic Training Michelle Odai, MS, LAT, ATC, CSCS Florida International University.
An overview of off-label drug use Ignoring the Label Samantha Rue.
Objectives Why we need DHCPL Situations that call for a DHCPL Definitions DHCPL itself–content, presentation, process Target audience Current and future.
Concerns in Medication Safety in Regards to the Older Adult Population Stephanie A. Ball, Taylor W. Brickley, Macey F. Davenport, Kelly L. Erexson, Emily.
Joint NDAC/PAC meeting October 18, 2007 OTC Cold and Cough Products: Use in Children Advisory Committee Meeting October 18, 2007 Joel Schiffenbauer, MD.
Medication Management. Medications and You Know your medications and how to take them.
Overview of the New Content and Format Requirements for Prescription Drug Labeling.
Pharmacologic Principles Chapter 1, 2, 3. Understanding Nurses must understand both + and – effects of drugs Pharmacotherapeutics –u–use of drugs and.
The basics about over-the-counter and prescription drugs. 1 Medicine 101.
An Update on NSAID Labeling and Data Review DSaRM Advisory Committee February 10, 2006 Sharon Hertz, M.D. Deputy Director Division of Anesthesia, Analgesia,
Eureka Pre-Clinical Investigation Animal toxicology Animal pharmacokinetics/ pharmacodynamics Clinical Investigation Phase I Safety and pharmacology Phase.
CASTRO VALLEY ADULT AND CAREER EDUCATION CMA PROGRAM FOOD AND DRUG ADMINISTRATION.
AccessPharmacy from McGraw-Hill is the most comprehensive online resource available for pharmacy education.
Downstream Use of Structured Product Labeling Thomas R. Bizzaro, R.Ph. Vice President, Health policy and Industry Relations SPL/DailyMed Jamboree Workshop.
Chapter 1. OBJECTIVES  see p-2 of text book KEY TERMS / CONCEPTS  controlled substances  Drug Enforcement Administration (DEA)  drug standards  Food.
DRUGS AND MEDICINE Lesson 1. How Medicines Help You A drug is a substance that changes the way the body and mind works. Examples?
Introduction to Pharmacology PHARM TECH. Pharmacology  Pharmacology is the science that deals with the study of therapeutic (beneficial) agents.  Knowledge.
The Role of Medicines Lesson #2 Ch. 19 Pg
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 2 Application of Pharmacology in Nursing Practice.
Using Medicines Safely (2:50) Click here to launch video Click here to download print activity.
Principles of Medication Administration and Medication Safety Chapter 7 Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of.
Prof. Moustafa M. Mohamed Vice dean Dr. Safa Ahmed El-askary Faculty of Allied Medical Science Pharos University in Alexandria Development and Regulation.
Focus on Nursing Pharmacology
Labeling and Electronic Initiatives Rachel E. Behrman M.D., M.P.H. Deputy Director, Office of Medical Policy CDER FDA Science Board, April 15, 2005.
Injection – SQ, IM, ID Insulin Injection and/or Selected Medications SECTION N MEDICATIONS January 19, PM.
General Regulatory Issues in the Development of Drugs Intended for Treatment of Chronic Illness Sharon Hertz, M.D. Medical Officer Division of Anesthetic,
Update on Current FDA Labeling Initiatives Iris P. Masucci, PharmD, BCPS Center for Drug Evaluation and Research FDA November 16, 2006 Pediatric Advisory.
Impact of Multidisciplinary Team Care on Older People with Polypharmacy Liang-Kung Chen Center for Geriatrics and Gerontology Taipei Veterans General Hospital.
Jamie Bango Lindsey Croker Kristen Lantz Achidi Ndiforchu.
Principles of Pharmacology Brenda Rowe, RN, MN, JD.
Pharmacy Agencies Drug Development and Control Health Science Pharmacy Technician Virginia Parker.
27 June 2000Victor F. C. Raczkowski, M.D.1 Risk-Management Options Victor F. C. Raczkowski, M.D., M.S. Gastrointestinal Drugs Advisory Committee 27 June.
Meet & Greet. Welcome Objectives: 1. Review the core terminology used in pharmacology. 2. Discuss the features of the “perfect” drug. 3. Examine the.
Social Media: The Next Generation of Healthcare Communication Ben Miller Mark Ryan.
Grant Macdonald.  Appropriate polypharmacy describes treatment where a patient has multiple morbidities, and/or a complex condition, that is being managed.
Community Education Promoting Informed Medicine Use.
Off-label Use.
Prison Pain Formulary Background Denise Farmer April 2016.
The Nursing Process and Drug Therapy
FDB (First Databank, Inc.)
The Top apps in pediatrics for your calls and shifts Dr
Using Medicines Safely (2:50)
CHAPTER 4 Information Management in Pharmacy.
Does the Beer’s Criteria Influence Prescribing for Geriatric Patients?
Antineoplastic Medications
The Role of Medicines Lesson #2 Ch. 19 Pg
Labeling and Electronic Initiatives
Black Box Warning What You Need To Know.
Principles of Pharmacology
Presenter : Wayne Chen 陳旭瑋
AGREEMENT FOR TRANSPARENCY The Case of Mexico
Using Medicines Safely (2:50)
Health Information Systems: Functional Capacity
Opening an IND: Investigator Perspective
APOLLOJAMES LECTURER NANDHA COLLEGE OF PHARMACY
Tobey Clark, Director*, Burlington USA
Updates to the PhRMA Code on Interactions with Healthcare Professionals National Pharma Audioconference August 5, 2008.
Compounded Drugs and Lack of Premarket FDA-Approval
Let’s talk medicines safety
Interprofessional Approach to Managing Adverse Events of PI3K Inhibitors.
Presentation transcript:

For Nurses and healthcare providers “Epocrates” App For Nurses and healthcare providers By: Susan Perls

Description Goals Consult in-depth, peer-reviewed disease content developed in collaboration with BMJ. Look up concise monographs for popular herbals and other supplements. Provide clinical practice guidelines for healthcare professionals. Provide in-depth disease content and alternative medicines.

Purpose (Use/Value) Review evidence-based, patient-specific guidelines condensed for the moments of care.  Check for potentially harmful interactions between up to 30 drugs at a time  Send secure text messages to colleagues or create group chats with care teams. 

Drug Information Review drug prescribing and safety information for thousands of brand, generic and OTC drugs. Drug information includes: Adult and pediatric dosing for FDA-approved and off-label indications Black box warnings, contraindications, adverse reactions and drug interactions Safety/monitoring, including pregnancy risk categories, location safety ratings, monitoring parameters and similar drug names Pharmacology, including metabolism, excretion, subclass and mechanism of action Manufacturer, DEA/FDA status and approximate retail pricing

RECOGNITION #1 Medical Reference App Among U.S. Physicians (Manhattan Research)  Most Important Medical App (Annual Modern Healthcare reader survey)  Best App for HCP’s (Medical Marketing and Media)  #1

Where can you get this app? http://www.epocrates.com/products/features Cost: FREE Sign up today to explore features and reach clinicians! Sign Up Now!